ALLMedicine™ Thrombosis Center
Research & Reviews 28,533 results
https://doi.org/10.1007/s11239-022-02691-9
Journal of Thrombosis and Thrombolysis; Janse van Rensburg WJ, Haupt L
Aug 14th, 2022 - Thrombosis is a potentially life-threatening condition related to roughly a quarter of all deaths globally. Many of these deaths occur inside healthcare facilities due to possibly preventable causes. Therefore, understanding the etiological factor...
https://doi.org/10.1016/j.critrevonc.2022.103782
Critical Reviews in Oncology/hematology; Kacimi SEO, Moeinafshar A et. al.
Aug 13th, 2022 - Venous thromboembolism (VTE) is a clinical disease that includes deep vein thrombosis and pulmonary embolism. Amongst its underlying risk factors, cancer is of great importance. Stasis, endothelial injury, and hypercoagulability result in clot for...
https://doi.org/10.1016/j.ejvs.2022.07.048
European Journal of Vascular and endoVascular Surgery : T... Bontinis V, Antonopoulos CN et. al.
Aug 13th, 2022 - To assess the efficacy and safety of carotid artery stenting for the treatment of extracranial carotid artery dissection (CAD). Systematic review using Medline, Scopus, EMBASE and Cochrane Library. A systematic search was performed according to th...
https://doi.org/10.1016/j.ajem.2022.08.009
The American Journal of Emergency Medicine; Aydemir B, Hoyle C et. al.
Aug 13th, 2022 - Phlegmasia cerulea dolens (PCD) is a rare condition characterized by a severely swollen, cyanotic, blue extremity due to a large proximal (iliofemoral) deep venous thrombosis extending into the collateral veins. Mortality in PCD ranges 20-40%. Due...
https://doi.org/10.1182/blood.2022016342
Blood van Moorsel MVA, de Maat S et. al.
Aug 13th, 2022 - Recombinant human tissue plasminogen activator (rh-tPA) is an important thrombolytic agent for treatment of acute ischemic stroke (AIS). It requires fibrin binding for plasminogen activation. In contrast, Microlyse, a novel thrombolytic agent, req...
Guidelines 68 results
https://doi.org/10.1016/j.jhep.2021.09.003
Journal of Hepatology; ,
Mar 19th, 2022 - The prevention and management of bleeding and thrombosis in patients with cirrhosis poses several difficult clinical questions. These Clinical Practice Guidelines have been developed to provide practical guidance on debated topics, including curre...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566097
Blood Advances; Cuker A, Tseng EK et. al.
Nov 3rd, 2021 - COVID-19-related acute illness is associated with an increased risk of venous thromboembolism (VTE). These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care pr...
https://rcm.imrpress.com/article/2021/2153-8174/2153-8174-22-3-545.shtml
Reviews in Cardiovascular Medicine; McCullough PA, .
Sep 24th, 2021 - Hydroxychloroquine is the most widely prescribed intracellular anti-infective for human SARS-CoV-2 infection and COVID-19 syndrome. There have been 296 studies, 220 of which are peer reviewed, 246 comparing treatment and control groups [1]. This a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416320
Blood Advances; Cuker A, Tseng EK et. al.
Sep 3rd, 2021 - COVID-19-related critical illness is associated with an increased risk of venous thromboembolism (VTE). These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355884
Gut Veitch AM, Radaelli F et. al.
Aug 8th, 2021 - This is a collaboration between the British Society of Gastroenterology (BSG) and the European Society of Gastrointestinal Endoscopy (ESGE), and is a scheduled update of their 2016 guideline on endoscopy in patients on antiplatelet or anticoagulan...
Drugs 390 results see all →
Clinicaltrials.gov 2,607 results
https://clinicaltrials.gov/ct2/show/NCT01546987
Aug 12th, 2022 - OBJECTIVES: Primary To evaluate the difference in overall survival of patients with clinically localized prostate cancer with unfavorable prognostic features between a) standard treatment (androgen-deprivation therapy [ADT] + radiotherapy) and b) ...
https://clinicaltrials.gov/ct2/show/NCT03948958
Aug 12th, 2022 - A Totally Implantable Venous Access Device (TIVAD) or so called implantable port that is no longer in use for intravenous therapy, should be removed or flushed at established intervals to promote and maintain patency. The maintenance procedure con...
https://clinicaltrials.gov/ct2/show/NCT00198068
Aug 12th, 2022 - Thrombosis and pregnancy loss are common features of systemic lupus erythematosus (SLE), particularly in the presence of antiphospholipid (aPL) antibodies. The in vivo mechanisms by which aPL antibodies lead to vascular events and, specifically, t...
https://clinicaltrials.gov/ct2/show/NCT05495178
Aug 12th, 2022 - Inflammatory bowel disease (IBD) prevalence is expected to reach 1% of the population in many regions over the next decade [1]. despite the fact that the primary clinical manifestations of IBD are centred in the gastrointestinal tract, 25-40% of I...
https://clinicaltrials.gov/ct2/show/NCT05439863
Aug 11th, 2022 - Transcatheter aortic valve replacement (TAVR) has became an important treatment of severe aortic stenosis (AS). Several randomized clinical trials showed that TAVR was non-inferior or superior to surgical aortic valve replacement (SAVR). However, ...
News 3,543 results
https://www.medscape.com/viewarticle/978812
Aug 8th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Updated clinical practice guidelines for the treatment and prevention of venous thromboembolism (VTE) for patients with cancer, including those wi...
https://www.medscape.com/viewarticle/978612
Aug 4th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 vaccination does not increase the risk of acute liver injury, suggests a study that found that acute liver injury is far more common from...
https://www.mdedge.com/familymedicine/article/256352/preventive-care/colchicine-may-decrease-cardiovascular-events-patients
MDedge Family Medicine; Leslie Griffin, MD, Julia Groce, MD et. al.
Jul 19th, 2022 - ILLUSTRATIVE CASE A 62-year-old woman with a past medical history of type 2 diabetes, hyperlipidemia, hypertension, and remote myocardial infarction (MI) presents to her primary care office for a preventive visit. She is a nonsmoker and has been t.
https://www.medscape.com/viewarticle/977392
Jul 18th, 2022 - The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Right ventricular (RV) dilation or dysfunction in patients hospitalized with acute COVID-19 is associated with an elevat...
https://www.medscape.com/viewarticle/976487
Jul 1st, 2022 - A new Scandinavian study has confirmed previous data showing increased rates of cerebral venous thrombosis and thrombocytopenia after the AstraZeneca COVID-19 vaccine. The study also showed higher rates of several thromboembolic and thrombocytopen...